Preclinical studies in mice demonstrate significant reductions in fat mass and body weight without changes in food intake
Severe caloric restriction sometimes impairs concentration and mental clarity, likely due to low glucose availability and potential micronutrient deficiencies
Place the cap on the needle and remove
Laboratory testing including comprehensive blood work helps establish baseline status and monitor treatment progress through appropriate retesting intervals
Most people start BPC-157 at 200 to 500 mcg per day
Symptoms include shakiness, sweating, hunger, anxiety, confusion, dizziness, blurred vision, and at the severe end, seizure or loss of consciousness